Myocardial infarction with non-obstructive coronary arteries is a working diagnosis for several heart disorders. Previous studies on anxiety and depression in patients with myocardial infarction with non-obstructive coronary arteries are lacking. Our aim was to investigate the prevalence of anxiety and depression among patients with myocardial infarction with non-obstructive coronary arteries.
Methods
We included 99 patients with myocardial infarction with non-obstructive coronary arteries together with age- and sex-matched control groups who completed the Beck Depression Inventory and the Hospital Anxiety and Depression Scale (HADS) 3 months after the acute event.
Results
Using the Beck Depression Inventory, we found that the prevalence of depression in patients with myocardial infarction with non-obstructive coronary arteries (35%) was higher than in healthy controls (9%; P = .006) and similar to that of patients with coronary heart disease (30%; P = .954). Using the HADS anxiety subscale, we found that the prevalence of anxiety in patients with myocardial infarction with non-obstructive coronary arteries (27%) was higher than in healthy controls (9%; P = .002) and similar to that of patients with coronary heart disease (21%; P = .409). Using the HADS depression subscale, we found that the prevalence of depression in patients with myocardial infarction with non-obstructive coronary arteries (17%) was higher than in healthy controls (4%; P = .003) and similar to that of patients with coronary heart disease (13%; P = .466). Patients with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome scored higher on the HADS anxiety subscale than those without (P = .028).
Conclusions
This is the first study on the mental health of patients with myocardial infarction with non-obstructive coronary arteries to show that prevalence rates of anxiety and depression are similar to those in patients with coronary heart disease.
To read this article in its entirety please visit our website.
-Maria Daniel, MD, Stefan Agewall, PhD, Felix Berglund, A Medicine Medical Student, Kenneth Caidahl, PhD, Olov Collste, PhD, Christina Ekenbäck, MD, Mats Frick, PhD, Loghman Henareh, PhD, Tomas Jernberg, PhD, Karin Malmqvist, PhD, Karin Schenck-Gustafsson, PhD, Jonas Spaak, PhD, Örjan Sundin, PhD, Peder Sörensson, PhD, Shams Y-Hassan, MD, Claes Hofman-Bang, PhD, Per Tornvall, PhD
This article originally appeared in the September issue of The American Journal of Medicine.